Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 901–950 of 1,812 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04665362	IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC	unknown	Phase 1	10	Liang PengOTHER	0	Jan 22, 2021	clinicaltrials
NCT03271515	Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL	unknown	Phase 1	20	Beijing Doing Biomedical Co., Ltd.INDUSTRY	1	Jan 20, 2021	clinicaltrials
NCT03840317